ArticleMedical oncology (Northwood, London, England)2018

Evaluation of relative dose intensity during the early phase of first-line sunitinib treatment using a 2-week-on/1-week-off regimen for metastatic renal cell carcinoma.

Kana Iwamoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.